FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

DEPPE MICHAEL J
2. Issuer Name and Ticker or Trading Symbol

QUEST DIAGNOSTICS INC [ DGX ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
VP, Corp. Controller & CAO
(Last)          (First)          (Middle)

500 PLAZA DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)

3/9/2021
(Street)

SECAUCUS, NJ 07094
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 3/9/2021  A  1884 (1)A$115.42 27485 D  
Common Stock 3/9/2021  F  684 (2)D$115.42 26802 (3)D  
401(k)         641 (4)I 401(k) 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 19, 2018, approved in accordance with the requirements of Rule 16b-3(d).
(2) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.
(3) The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
(4) These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
DEPPE MICHAEL J
500 PLAZA DRIVE
SECAUCUS, NJ 07094


VP, Corp. Controller & CAO

Signatures
William J. O'Shaughnessy, Jr. Attorney in Fact for Michael J. Deppe3/11/2021
**Signature of Reporting PersonDate

Quest Diagnostics (NYSE:DGX)
Historical Stock Chart
Von Feb 2024 bis Mär 2024 Click Here for more Quest Diagnostics Charts.
Quest Diagnostics (NYSE:DGX)
Historical Stock Chart
Von Mär 2023 bis Mär 2024 Click Here for more Quest Diagnostics Charts.